CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-16 | Sanders Corazon (Corsee) D. Director | Grant or award | +7,800 | 7,800 | ||
| 2021-06-16 | Sanders Corazon (Corsee) D. Director | Grant or award · Share Option (Right to Buy) | +17,498 | 17,498 | ||
| 2021-06-16 | su Jingshyh S Director | Grant or award | +7,800 | 7,800 | ||
| 2021-06-16 | su Jingshyh S Director | Grant or award · Share Option (Right to Buy) | +17,498 | 17,498 | ||
| 2021-06-16 | BAKER BROS. ADVISORS LP Director | Grant or award | +15,600 | 34,185 | ||
| 2021-06-16 | BAKER BROS. ADVISORS LP Director | Grant or award | +15,600 | 34,189 | ||
| 2021-06-16 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +34,996 | 34,996 | ||
| 2021-06-10 | Chen Timothy Yung-Cheng Director | Option exercise | +2,836 | $31.59 | $90K | 2,836 |
| 2021-06-10 | Chen Timothy Yung-Cheng Director | Sale | −684 | $350.08 | $239K | 2,152 |
| 2021-06-10 | Chen Timothy Yung-Cheng Director | Sale | −508 | $351.79 | $179K | 1,644 |
| 2021-06-10 | Chen Timothy Yung-Cheng Director | Sale | −1,339 | $352.74 | $472K | 305 |
| 2021-06-10 | Chen Timothy Yung-Cheng Director | Sale | −305 | $353.69 | $108K | 0 |
| 2021-06-10 | Chen Timothy Yung-Cheng Director | Option exercise · Share Option (Right to Buy) | −36,868 | 188,926 | ||
| 2021-06-09 | Chen Timothy Yung-Cheng Director | Option exercise | +3,164 | $31.59 | $100K | 3,164 |
| 2021-06-09 | Chen Timothy Yung-Cheng Director | Sale | −1,363 | $350.43 | $478K | 1,801 |
| 2021-06-09 | Chen Timothy Yung-Cheng Director | Sale | −1,201 | $351.70 | $422K | 600 |
| 2021-06-09 | Chen Timothy Yung-Cheng Director | Sale | −600 | $352.74 | $212K | 0 |
| 2021-06-09 | Chen Timothy Yung-Cheng Director | Option exercise · Share Option (Right to Buy) | −41,132 | 225,794 | ||
| 2021-06-07 | Wu Xiaobin President, COO & GM China | Sale | −2,825 | $352.33 | $995K | 573 |
| 2021-06-07 | Wu Xiaobin President, COO & GM China | Sale | −571 | $353.57 | $202K | 2 |
Page 70 of 71 · 1,406 trades